Definium Therapeutics Inc (DFTX)

Apr 17, 2026

Is It Too Late To Consider Definium Therapeutics (DFTX) After Its Strong 1 Year Run? - Yahoo Finance

Apr 17, 2026

Apr 17, 2026

Definium Therapeutics Anxiety Drug A Multi-Billion Opportunity: Analyst - Benzinga

Apr 17, 2026

Apr 17, 2026

Definium: 'Strong Buy' Maintained On Several Anticipated 2026 Milestones (NASDAQ:DFTX) - Seeking Alpha

Apr 17, 2026

Apr 17, 2026

DFTX Initiates Coverage On Stifel -- Rating Set to Buy - GuruFocus

Apr 17, 2026

Apr 17, 2026

Can an LSD candidate do for anxiety what Spravato did for depression? - Pharma Voice

Apr 17, 2026

Apr 17, 2026

Stifel Initiates Definium Therapeutics at Buy With $30 Price Target - marketscreener.com

Apr 17, 2026

Apr 17, 2026

Definium Therapeutics (DFTX) Short Interest & Short Float | Updated Apr 2026 - MarketBeat

Apr 17, 2026

Apr 16, 2026

DFTX Maintains Buy Rating by Canaccord Genuity -- Price Target R - GuruFocus

Apr 16, 2026

Apr 16, 2026

Stifel initiates Definium stock with buy rating on anxiety drug By Investing.com - Investing.com Australia

Apr 16, 2026

Apr 16, 2026

Definium Therapeutics Teases 3 Phase III DT120 Readouts in 2026, Starting Late Q2 MDD Data - MarketBeat

Apr 16, 2026

Apr 16, 2026

Definium Therapeutics Price Target Raised to $38.00/Share From $25.00 by Canaccord Genuity - Moomoo

Apr 16, 2026

Apr 15, 2026

Top Definium Therapeutics (DFTX) Competitors 2026 - MarketBeat

Apr 15, 2026

Apr 14, 2026

Definium Therapeutics (NASDAQ:DFTX) Sets New 1-Year HighStill a Buy? - MarketBeat

Apr 14, 2026

Apr 13, 2026

DFTX Options Volatility — NASDAQ:DFTX - TradingView — Track All Markets

Apr 13, 2026

Apr 12, 2026

Definium Therapeutics Sees Insider Stock Selling - 富途牛牛

Apr 12, 2026

Apr 12, 2026

DFTX: Definium Therapeutics, Inc.Income Statment - Zacks Investment Research

Apr 12, 2026

Apr 12, 2026

All News for DFTX : Definium Therapeutics, Inc. - Zacks Investment Research

Apr 12, 2026

Apr 11, 2026

symbol__ Stock Quote Price and Forecast - CNN

Apr 11, 2026

Apr 10, 2026

DFTX: Piper Sandler Initiates Coverage with Overweight Rating | - GuruFocus

Apr 10, 2026

Apr 10, 2026

Definium Therapeutics stock hits 52-week high at 21.99 USD - Investing.com

Apr 10, 2026

Apr 10, 2026

Definium Therapeutics stock hits 52-week high at 21.99 USD By Investing.com - Investing.com UK

Apr 10, 2026

Apr 10, 2026

Definium Therapeutics (NASDAQ:DFTX) Now Covered by Analysts at Piper Sandler - MarketBeat

Apr 10, 2026

Apr 10, 2026

Piper Sandler Initiates Definium Therapeutics at Overweight - marketscreener.com

Apr 10, 2026

Apr 10, 2026

Piper Sandler initiates Definium stock with Overweight rating - Investing.com

Apr 10, 2026

Apr 10, 2026

Piper Sandler initiates Definium stock with Overweight rating By Investing.com - Investing.com India

Apr 10, 2026

Apr 09, 2026

Investment bank Piper Sandler announced the official initiation of coverage on biopharmaceutical company Definium Therapeutics Inc, assigning it an "Overweight" rating. - Bitget

Apr 09, 2026

Apr 09, 2026

Definium Therapeutics to Participate at Upcoming Investor Conferences and Events - marketscreener.com

Apr 09, 2026

Apr 08, 2026

Definium Therapeutics Inc (DFTX) Stock Price Quote Today & Current Price Chart | Capital.com UAE - Capital.com

Apr 08, 2026

Apr 07, 2026

Definium Therapeutics, Inc. (DFTX) stock price, news, quote and history - Yahoo Finance UK

Apr 07, 2026

Apr 06, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

Apr 06, 2026

Apr 05, 2026

Price performance - Yahoo Finance Singapore

Apr 05, 2026

Apr 04, 2026

Do Definium Therapeutics’ (DFTX) New Hires Hint At A Deeper Bet On Anxiety Treatments? - Sahm

Apr 04, 2026

Apr 03, 2026

Can Definium Therapeutics (DFTX) Turn GAD Prevalence And DT120 Breakthrough Status Into Durable Advantage? - Yahoo Finance

Apr 03, 2026

Apr 03, 2026

Total non-current liabilities of Definium Therapeutics, Inc. – NASDAQ:DFTX - TradingView — Track All Markets

Apr 03, 2026

Apr 02, 2026

Analysts Offer Insights on Healthcare Companies: Definium Therapeutics (DFTX) and Eli Lilly & Co (LLY) - The Globe and Mail

Apr 02, 2026

Apr 02, 2026

Definium Therapeutics stock hits 52-week high at 19.78 USD By Investing.com - Investing.com Canada

Apr 02, 2026

Apr 01, 2026

Definium Therapeutics (NASDAQ:DFTX) Sets New 52-Week HighHere's Why - MarketBeat

Apr 01, 2026

Apr 01, 2026

Definium Therapeutics stock hits 52-week high at 19.78 USD - Investing.com

Apr 01, 2026

Apr 01, 2026

LifeSci Capital Maintains Definium Therapeutics(DFTX.US) With Buy Rating, Maintains Target Price $32 - Moomoo

Apr 01, 2026

Mar 31, 2026

New Definium Therapeutics Study Published in the Journal of Mood and Anxiety Disorders Reveals Increasing Prevalence and Burden of Generalized Anxiety Disorder in the United States - BioSpace

Mar 31, 2026

Mar 31, 2026

Definium Therapeutics (DFTX) Study Highlights Rising GAD Rates i - GuruFocus

Mar 31, 2026

Mar 31, 2026

Anxiety disorder prevalence rises to 6.6% in U.S., study finds By Investing.com - Investing.com Australia

Mar 31, 2026

Mar 31, 2026

Anxiety disorder prevalence rises to 6.6% in U.S., study finds - Investing.com

Mar 31, 2026